Authorised Prescriber Pathway Services
Comprehensive support for medical practitioners navigating the TGA Authorised Prescriber scheme for medicinal cannabis and other therapeutic products.
Navigating the TGA Authorised Prescriber Pathway
The Therapeutic Goods Administration (TGA) administers the Therapeutic Goods Act 1989, the Therapeutic Goods Regulations 1990, and various Orders and Determinations that regulate the quality, safety, and efficacy of therapeutic goods in Australia. The TGA also regulates access to "unapproved" therapeutic goods that have not yet received general approval.
Authorised Prescriber Pathway service provides expert guidance through complex regulatory requirements. We help medical practitioners efficiently navigate the process of becoming an Authorised Prescriber, allowing them to prescribe unapproved therapeutic products like medicinal cannabis to patients under their care.
Our comprehensive support services guide practitioners through each stage of the process, from eligibility assessment and training to application support and ongoing compliance management.
Eligibility Assessment
We assist medical practitioners in determining their eligibility to become Authorised Prescribers based on their qualifications, training, and expertise in specific therapeutic areas.
-
Evaluation of qualifications and clinical experience
-
Assessment of therapeutic knowledge in specific areas
-
Identification of additional training requirements
-
Personalized eligibility reports with recommendations
Training and Education
We source training on the endocannabinoid system and cannabis pharmacology to meet TGA requirements for Authorised Prescribers.
-
Comprehensive training on the endocannabinoid system
-
Education on medicinal cannabis products and formulations
-
Dosing considerations and therapeutic applications
-
Adverse effects, drug interactions, and contraindications
-
Regular updates on regulatory changes and research findings
HREC Endorsement Support
We provide comprehensive assistance in preparing and submitting applications for Human Research Ethics Committee (HREC) endorsement, a critical step in the Authorised Prescriber process.
-
Preparation of HREC application documentation
-
Development of clinical protocols and treatment plans
-
Supporting evidence compilation
-
Application submission and follow-up assistance
-
Typical processing time: 3 weeks
TGA Application Support
We guide medical practitioners through the Standard Pathway application process for Authorised Prescriber status using the TGA's SAS and AP Online System.
-
Step-by-step guidance through the online application system
-
Preparation of supporting documentation
-
Application review before submission
-
Follow-up communication with TGA
-
Typical approval time: 10 business days
Compliance and Reporting
We assist practitioners in meeting their ongoing compliance and reporting obligations to maintain Authorised Prescriber status with both the TGA and HREC.
-
Preparation and submission of six-monthly reports
-
Tracking of patient numbers by medicine category
-
Monitoring of federal and state legislation changes
-
Compliance guidance for prescription and supply requirements
-
Renewal application support
Ongoing Advisory Services
We provide continuous guidance on regulatory developments, clinical best practices, and therapeutic advances to support practitioners in their prescribing activities.
-
Updates on regulatory changes affecting prescribing
-
Clinical guidance on product selection and dosing
-
Information on new therapeutic applications
-
Advisory support for complex patient cases
-
Access to our network of specialists and resources
Our Services
The Authorised Prescriber Pathway Process
Initial Assessment
We begin with a thorough assessment of the practitioner's eligibility, identifying any additional training or expertise needed to meet TGA requirements.
2
4
HREC Application
We prepare and submit the application for HREC endorsement, including all required documentation, treatment protocols, and supporting evidence.
Ongoing Compliance Support
After approval (typically within 10 business days), we provide ongoing support with compliance requirements, including six-monthly reports to TGA and HREC.
1
Training Completion
Practitioners complete our HREC-endorsed training on the endocannabinoid system, pharmacology of cannabinoids, and therapeutic applications of medicinal cannabis.
3
TGA Application Submission
Once HREC endorsement is obtained (typically within 3 weeks), we guide practitioners through the TGA online application process for Authorised Prescriber status.
5
Benefits for Medical Practitioners
We source CPD approved education provider by the RACGP (Activity ID: 651070), for comprehensive training provides practitioners with specialized knowledge about emerging therapeutic options, enhancing clinical expertise and expanding professional capabilities.
Expanded Patient Options
Becoming an Authorised Prescriber allows practitioners to offer patients access to promising treatments that aren't yet fully approved, enhancing treatment options for conditions with limited alternatives.
Streamlined Patient Access
Unlike per-patient SAS applications, Authorised Prescriber status allows immediate prescription to appropriate patients without individual TGA approvals, improving treatment timing and accessibility.
Ongoing Support
Our service doesn't end with approval; we provide continuous guidance on regulatory changes, emerging research, and best practices to support your prescribing activities and ensure ongoing compliance.